Drug Profile
Embryonic neural cell therapy-Parkinson's Disease - CellFactors
Alternative Names: Parkinson's disease cell therapy - CellFactorsLatest Information Update: 09 Aug 2007
Price :
$50
*
At a glance
- Originator CellFactors
- Class
- Mechanism of Action Dopaminergic cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Parkinson's disease
Most Recent Events
- 09 Aug 2007 Discontinued - Preclinical for Parkinson's disease in United Kingdom (Intracerebal)
- 19 Jul 2001 Preclinical development for Parkinson's disease in United Kingdom (Intracerebal)